Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Sven Erickson"'
Autor:
Anders Lehmann, Thore Johansson, A. Jonas Ekstrand, Christophe Quéva, Anders Edlund, Susanne Elg, Sven Erickson, Jan P. Mattsson, Marianne Bremner-Danielsen
Publikováno v:
British Journal of Pharmacology. 140:315-322
1. Activation of GABA(B) receptors evokes hypothermia in wildtype (GABA(B(1))+/+) but not in GABA(B) receptor knockout (GABA(B(1))-/-) mice. The aim of the present study was to determine the hypothermic and behavioural effects of the putative GABA(B)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05b89490463e882c9809602b06a64732
https://doi.org/10.1038/sj.bjp.0705447
https://doi.org/10.1038/sj.bjp.0705447
Autor:
Sampsa Matikainen, Stefan Einhorn, Lena Thyrell, Sven Erickson, Olle Sangfelt, Ilkka Julkunen, Dan Grandér
Publikováno v:
European Journal of Biochemistry. 269:29-37
It has previously been shown that IFN-alpha is a potent inhibitor of IL-2 induced proliferation in primary T-lymphocytes, by selectively abrogating the downstream effects of IL-2 on the core cell cycle machinery regulating the G1/S transition. Theore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa44fce9f0e9001ae2293386643bcc7b
https://doi.org/10.1046/j.0014-2956.2002.02626.x
https://doi.org/10.1046/j.0014-2956.2002.02626.x
Autor:
Dawei Xu, Astrid Gruber, Michael Szeps, Dan Grandér, Sven Erickson, Olle Sangfelt, Stefan Einhorn, Pavel Pisa
Publikováno v:
Blood. 96:4313-4318
Recently, the derepressed expression of the catalytic subunit of telomerase, human telomerase reverse transcriptase (hTERT), the enzyme that elongates telomeres, has been implicated as an important step in the immortalization process. The exact regul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67942f8d8af6e087a17ac0187fd42471
https://doi.org/10.1182/blood.v96.13.4313.h8004313_4313_4318
https://doi.org/10.1182/blood.v96.13.4313.h8004313_4313_4318
Autor:
Anna Gustafsson, Stefan Einhorn, Juan Castro, Thomas Heiden, Sven Erickson, Olle Sangfelt, Dan Grandér
Publikováno v:
Oncogene. 18:2798-2810
One prominent effect of IFNs is their cell growth-inhibitory activity. The mechanism behind this inhibition of proliferation is still not fully understood. In this study, the effect of IFN-alpha treatment on cell cycle progression has been analysed i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27d79b0e706a3657fcc5949fe19bf9d3
https://doi.org/10.1038/sj.onc.1202609
https://doi.org/10.1038/sj.onc.1202609
Publikováno v:
Oncogene. 17:595-602
Little is known about the molecular background to senescence in T-lymphocytes. In fibroblast systems replicative senescence has been shown to correlate with a number of changes in the expression of the proteins normally regulating progression through
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d694f3b62b11d0301161624529a9de8a
https://doi.org/10.1038/sj.onc.1201965
https://doi.org/10.1038/sj.onc.1201965
Publikováno v:
Leukemialymphoma. 44(6)
One prominent activity of Interferons (IFNs) is their ability to induce cell cycle arrest, and this effect has furthermore been proposed to be of major importance in mediating the clinical antitumor activity of IFNs. In several IFN sensitive establis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::195b9b06ad6ec7873b7a50deb6271e44
https://pubmed.ncbi.nlm.nih.gov/12854904
https://pubmed.ncbi.nlm.nih.gov/12854904
Autor:
Sven, Erickson, Sampsa, Matikainen, Lena, Thyrell, Olle, Sangfelt, Ilkka, Julkunen, Stefan, Einhorn, Dan, Grandér
Publikováno v:
European journal of biochemistry. 269(1)
It has previously been shown that IFN-alpha is a potent inhibitor of IL-2 induced proliferation in primary T-lymphocytes, by selectively abrogating the downstream effects of IL-2 on the core cell cycle machinery regulating the G1/S transition. Theore
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::db09a6bfc821cd742e5003632c7d1e1d
https://pubmed.ncbi.nlm.nih.gov/11784295
https://pubmed.ncbi.nlm.nih.gov/11784295
Autor:
Olle Sangfelt, Stefan Einhorn, Juan Castro, Lena Thyrell, Dan Grandér, Sven Erickson, Boris Zhivotovsky, Katja Pokrovskaja
Publikováno v:
Oncogene. 21(8)
Interferon alpha (IFNalpha) has been used in the treatment of several types of cancer for almost 30 years, yet the mechanism(s) responsible for its anti-tumoral action remains unknown. A variety of cellular responses, including inhibition of cell gro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf8c06248d2e9175f688c6a58d21a1c
https://pubmed.ncbi.nlm.nih.gov/11850845
https://pubmed.ncbi.nlm.nih.gov/11850845
Publikováno v:
Frontiers in Bioscience. 5:d479
The interferons (IFNs) are a group of cytokines, which in addition to their antiviral activity are capable of modulating a variety of cellular responses. One such prominent effect of IFNs is their potent antimitogenic action, which can be observed bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::779c0b971a9cacd30ef7fc7cfa71668b
https://doi.org/10.2741/sangfelt
https://doi.org/10.2741/sangfelt